These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 7679745)

  • 1. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
    Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
    J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide.
    Hunt AR; Johnson AJ; Roehrig JT
    Virology; 1990 Dec; 179(2):701-11. PubMed ID: 2146802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.
    Kinney RM; Johnson BJ; Welch JB; Tsuchiya KR; Trent DW
    Virology; 1989 May; 170(1):19-30. PubMed ID: 2524126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus.
    Johnson BJ; Kinney RM; Kost CL; Trent DW
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1951-60. PubMed ID: 3755750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes.
    Pereboev AV; Razumov IA; Svyatchenko VA; Loktev VB
    Arch Virol; 1996; 141(11):2191-205. PubMed ID: 8973533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
    Johnson BJ; Brubaker JR; Roehrig JT; Trent DW
    Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
    Hunt AR; Roehrig JT
    Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.
    Davis NL; Grieder FB; Smith JF; Greenwald GF; Valenski ML; Sellon DC; Charles PC; Johnston RE
    Arch Virol Suppl; 1994; 9():99-109. PubMed ID: 8032286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of antigenic structure of attenuated and virulent Venezuelan equine encephalomyelitis virus by means of monoclonal antibodies.
    Razumov IA; Agapov EV; Pereboev AV; Protopopova EV; Lebedeva SD; Loktev VB
    Biomed Sci; 1991; 2(6):615-22. PubMed ID: 1726775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins.
    Kinney RM; Johnson BJ; Brown VL; Trent DW
    Virology; 1986 Jul; 152(2):400-13. PubMed ID: 3088830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
    Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
    Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection.
    Agapov EV; Razumov IA; Frolov IV; Kolykhalov AA; Netesov SV; Loktev VB
    Arch Virol; 1994; 139(1-2):173-81. PubMed ID: 7529989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.